These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1636582)

  • 1. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
    Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1989 Dec; 80(6):1557-70. PubMed ID: 2513143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
    Clair WK; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Circulation; 1993 Apr; 87(4):1114-22. PubMed ID: 8462140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.
    Page RL; Wilkinson WE; Clair WK; McCarthy EA; Pritchett EL
    Circulation; 1994 Jan; 89(1):224-7. PubMed ID: 8281651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation.
    Chen YJ; Chen SA; Tai CT; Wen ZC; Feng AN; Ding YA; Chang MS
    J Am Coll Cardiol; 1998 Sep; 32(3):732-8. PubMed ID: 9741520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
    Anderson JL
    Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
    Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia due to atrioventricular nodal reentry.
    Hurwitz JL; German LD; Packer DL; Wharton JM; McCarthy EA; Wilkinson WE; Prystowsky EN; Pritchett EL
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):705-10. PubMed ID: 1695348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
    Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia.
    Hamer ME; Wilkinson WE; McCarthy EA; Page RL; Pritchett EL
    Pacing Clin Electrophysiol; 1995 Dec; 18(12 Pt 1):2155-7. PubMed ID: 8771127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
    Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
    Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL; Platt ML; Guarnieri T; Fox TL; Maser MJ; Pritchett EL
    Am J Cardiol; 1994 Sep; 74(6):578-84. PubMed ID: 8074041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
    Page RL; Pritchett EL; Connolly S; Wilkinson WE;
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):172-7. PubMed ID: 17916138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological studies in patients with paroxysmal supraventricular tachycardias but no electrocardiogram documentation: findings from a prospective registry.
    Lauschke J; Schneider J; Schneider R; Nesselmann C; Tischer T; Glass A; Bänsch D
    Europace; 2015 May; 17(5):801-6. PubMed ID: 25926475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic value of esophageal ECG and transesophageal atrial stimulation in paroxysmal supraventricular tachycardia].
    Pehrson SM; Blomström P
    Ugeskr Laeger; 1991 Nov; 153(48):3403-7. PubMed ID: 1957408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.